- Nachrichtendetail
-
21.05.2024 13:19:02 - dpa-AFX: *HALOZYME: BRISTOL MYERS SQUIBB GETS UPDATED ACTION DATE OF DEC. 29 FOR SUBCUTANEOUS NIVOLUMAB CO-FORMULATED WITH ENHANZE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 50,910 | 27.09.24 03:01:25 | +0,790 | +1,58% | 51,090 | 51,180 | 51,540 | 50,910 |
